• Impact of EU IVDR on companion diagnostic development
• Conformity route and medicinal product consultation
• EMA consultation
• Classification requirements
• Planning and coordination between pharma and diagnostics partners and notified body
• Performance studies of companion diagnostics
• Coordination with pertinent EU MDR requirements